Lepu Biopharma
Lepu Biopharma, a prominent player in the biopharmaceutical industry, is headquartered in China (CN) and operates extensively across Asia and beyond. Founded in 2001, the company has established itself as a leader in the development of innovative therapies, particularly in the fields of oncology and autoimmune diseases. Lepu Biopharma is renowned for its cutting-edge biologics and biosimilars, which are distinguished by their high quality and efficacy. The company has achieved significant milestones, including numerous product approvals and partnerships that enhance its market position. With a commitment to advancing healthcare solutions, Lepu Biopharma continues to make strides in the biopharmaceutical landscape, contributing to improved patient outcomes globally.
DitchCarbon Score
How does Lepu Biopharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Lepu Biopharma's score of 4 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Lepu Biopharma's reported carbon emissions
In 2022, Lepu Biopharma reported total carbon emissions of approximately 5,592,500 kg CO2e, a reduction from about 6,226,430 kg CO2e in 2021. The emissions breakdown for 2022 includes approximately 1,688,580 kg CO2e from Scope 1, primarily from stationary combustion, and about 3,903,920 kg CO2e from Scope 2, mainly related to purchased electricity. Despite these reductions, Lepu Biopharma has not established specific reduction targets or climate pledges, indicating a potential area for improvement in their climate commitments. The company’s emissions data reflects a commitment to monitoring and managing their carbon footprint, but further initiatives could enhance their sustainability efforts in line with industry standards.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | |
|---|---|---|
| Scope 1 | 2,148,540 | 0,000,000 |
| Scope 2 | 4,077,890 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Lepu Biopharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
